Age, body mass index and 2-hour plasma glucose are the major determinants of blood pressure in Chinese women newly diagnosed to have glucose intolerance

International Journal of Cardiology

Volumn 69, Issue 1, 1999, Pages 33-39

  Ko, Gary T C ^a   Chan, Juliana C N ^b   Cockram, Clive S ^b  

^a ALICE HO MIU LING NETHERSOLE HOSPITAL   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

2 Hour plasma glucose; Age; Body Mass Index; Chinese women; Diabetes; Hypertension

Indexed keywords

GLUCOSE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CHILD; CHINESE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BODY MASS INDEX; CHILD; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HONG KONG; HUMANS; HYPERTENSION; MIDDLE AGED; PREVALENCE; SMOKING; STATISTICS;

EID: 0033617306     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(99)00002-9     Document Type: Article

References (36)

1. Kaplan NM. Systemic hypertension: mechanism and diagnosis. In: Braunwald E, editor. Heart disease: a textbook of cardiovascular medicine, 5th ed. Philadelphia: Saunders, 1997:807-839.
2. Taylor S.I., Accili D., Imai Y. Insulin resistance or insulin deficiency: which is the primary cause of NIDDM? Diabetes. 43:1994;735-739.
3. Jarrett R., McCartney P., Keen H. The Bedford Survey: Ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycemic controls and risk indices for coronary heart disease in borderline diabetics. Diabetologia. 22:1982;79-84.
4. Kleinman J.C., Donahue R.P., Harris M.I., Finncane F.F., Madans J.H., Brock D.B. Mortality among diabetics in a national sample. Am J Epidemiol. 128:1988;389-401.
5. WHO Multinational Study Group, Fuller J.H., Head J. Blood pressure, proteinuria and their relationship with circulatory mortality: the WHO multinational study of vascular disease in diabetics. Diabet Metab. 15:1989;273-277.
6. Lorenzi M., Nordberg J.A., Toledo S. High glucose prolongs cell-cycle traversal of cultured human endothelial cells. Diabetes. 36:1987;1261-1267.
7. Pell S., D'Alonzo C.A. Some aspects of hypertension in diabetes mellitus. J Am Med Assoc. 202:1967;104-110.
8. Pacy P.J., Dodson P.M., Beevers M., Fletcher R.F., Taylor K.G. Prevalence of hypertension in White, Black and Asian diabetics. Diabet Med. 2:1985;125-130.
9. Tai T.Y., Chuang L.M., Chen C.J., Lin B.J. Link between hypertension and diabetes mellitus epidemiological study of Chinese adults in Taiwan. Diabetes Care. 14:1991;1013-1020.
10. World Health Organization: Diabetes Mellitus. Report of a WHO Study Group. Technical Report Series no. 727, Geneva, 1985.
11. The Task Force on Risk Reduction American Heart Association Science Advisory Guide to Primary Prevention of Cardiovascular Diseases. A Statement for Healthcare Professionals. Circulation. 95:1997;2329-2331.
12. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 153:1993;154.
13. Simonson D.C. Etiology and prevalence of hypertension in diabetic patients. Diabetes Care. 11:1988;821-827.
14. Fuller J.H. Epidemiology of hypertension associated with diabetes mellitus. Hypertension. 7(suppl. II):1985;3-7.
15. Teuscher A., Egger M., Hermal J.B. Diabetes and hypertension: blood pressure in clinical diabetic patients and a control population. Arch Intern Med. 149:1989;1942-1945.
16. Janka H.U., Dirschedl P. Systolic blood pressure as a predictor for cardiovascular disease in diabetes: a 5-year longitudinal study. Hypertension. 7(suppl. II):1985;90-94.
17. West K.M., Erdreich L.J., Stober J.A. A detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes. 29:1980;51-58.
18. Ishihara M., Yukimura Y., Aizawa T., Yamada T., Ohto K., Yoshizawa K. High blood pressure as risk factor in diabetic retinopathy development in NIDDM patients. Diabetes Care. 10:1987;10-25.
19. Nelson R.G., Wolfe J.A., Horton M.B., Pettitt D.J., Bennett P.H., Knowler W.C. Proliferative retinopathy in NIDDM: incidence and risk factors in Pima Indians. Diabetes. 38:1989;435-440.
20. Feldt-Rasmussen B., Mathiesen E.R., Deckert T. Effect of two years of strict metabolic control on progression of incipient diabetic nephropathy in insulin-dependent diabetics. Lancet. 2:1986;1300-1304.
21. Derby L., Warram J.H., Laffel L.M.B., Krolewski A.S. Elevated blood pressure predicts the development of persistent proteinuria in the presence of poor metabolic control in patients with type I diabetes. Diabet Metab. 15:1989;320-326.
22. Klein R., Klein B.E., Lee K.E., Cruickshanks K.J., Moss S.E. The incidence of hypertension in insulin-dependent diabetes. Arch Intern Med. 156:1996;622-627.
23. Norgaard K. Hypertension in insulin-dependent diabetes. Dan Med Bull. 43:1996;21-38.
24. Reaven P.D., Barrett-Connor E.L., Browner D.K. Abnormal glucose tolerance and hypertension. Diabetes Care. 13:1990;119-125.
25. Teuscher A., Egger M., Herman J.B. Diabetes and hypertension. Blood pressure in clinical diabetic patients and a control population. Arch Intern Med. 149:1989;1942-1945.
26. Fuller, J.H., Stevens, L.K., Diabetes Hypertension Study Group. Prevalence of hypertension among diabetic patients and its relation to vascular risk. J Hum Hypertens 1991.
27. Hirata-Dulas C.A., Rith-Najarian S.J., McIntyre M.C.et al. Risk factors for nephropathy and cardiovascular disease in diabetic Northern Minnesota American Indians. Clin Nephrol. 46:1996;92-98.
28. Ruilope L.M., Garcia-Robles R. How far should blood pressure be reduced in diabetic hypertensive patients? J Hypertens. 15:1997;S63-65.
29. Ko G.T.C., Chan J.C.N., Woo J.et al. Glycated hemoglobin and cardiovascular risk factors in Chinese subjects with normal glucose tolerance. Diabet Med. 15:1998;573-578.
30. Ko G.T.C., Chan J.C.N., Lau E., Woo J., Cockram C.S. Fasting plasma glucose as a screening test for diabetes and its relationship with cardiovascular risk factors in Hong Kong Chinese. Diabetes Care. 20:1997;170-172.
31. Ko G.T.C., Chan J.C.N., Woo J.et al. The effect of age on cardiovascular risk factors in Chinese women. Int J Cardiol. 61:1997;221-227.
32. Reaven G.M. Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
33. Rossetti L., Giaccari A., DeFronzo R.A. Glucose toxicity. Diabetes Care. 13:1990;610-630.
34. Lorenzi M., Montisano D.F., Toledo S., Barrieux A. High glucose induces DNA damage in cultured human endothelial cells. J Clin Invest. 77:1986;322-325.
35. Haller H. Postprandial glucose and vascular diseases. Diabet Med. 14(Suppl 3):1997;S50-S56.
36. Ko G.T.C., Chan J.C.N., Woo J.et al. Simple anthropometric indexes and cardiovascular risk factors in Chinese. Int J Obesity. 21:1997;995-1001.